Literature DB >> 23471861

Therapy for lysosomal acid lipase deficiency: replacing a missing link.

Gregory Grabowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23471861     DOI： 10.1002/hep.26366

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Hepatic entrapment of esterified cholesterol drives continual expansion of whole body sterol pool in lysosomal acid lipase-deficient mice.

Authors:  Amal Aqul; Adam M Lopez; Kenneth S Posey; Anna M Taylor; Joyce J Repa; Dennis K Burns; Stephen D Turley
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-21       Impact factor: 4.052

2.  Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver.

Authors:  Adam M Lopez; Kenneth S Posey; Stephen D Turley
Journal:  Biochem Biophys Res Commun       Date:  2014-10-18       Impact factor: 3.575

Review 3.  Sebelipase alfa: first global approval.

Authors:  Matt Shirley
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

4.  Lysosomal Acid Lipase Deficiency, a Rare Pathology: The First Pediatric Patient Reported in Colombia.

Authors:  Verónica Botero; Victor H Garcia; Catalina Gomez-Duarte; Ana M Aristizabal; Ana M Arrunategui; Gabriel J Echeverri; Harry Pachajoa
Journal:  Am J Case Rep       Date:  2018-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.